Limited number of Sarclisa single use vials may have been frozen during shipment
Brand(s)
Last updated
Summary
Product
SARCLISA
Issue
Health products - Product quality
What to do
Consult your healthcare provider for any health concerns.
Distribution
Nova Scotia
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Sarclisa |
Sarclisa |
DIN 02498243 |
Single-use vial |
500 mg/25 mL |
5F028A |
Issue
Units of the affected lot may have been frozen during shipping.
Only nine (9) units from the lot are being recalled from three (3) locations in Nova Scotia.
What you should do
- Only a limited number of units within the lot are affected by this recall. Do not assume your product is affected solely because the lot number appears in the table.
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Biologic or vaccine
Companies
Sanofi-aventis Canada Inc.
1755 Steeles Ave. West
Toronto, ON M2R 3T4
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Nova Scotia
Recall class
Type I
Recall date
Identification number
RA-82683
Get notified
Receive emails about new and updated recall and safety alerts.